The quantitative JAK2 V617F neutrophil allele burden does not correlate with thrombotic risk in essential thrombocytosis
Authors:
- 17 May 2007
- journal article
- Published by Springer Nature in Leukemia
- Vol. 21 (10) , 2210-2212
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Molecular mimicry in the chronic myeloproliferative disorders: reciprocity between quantitative JAK2 V617F and Mpl expressionBlood, 2006
- Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disordersBlood, 2006
- Essential thrombocythemias without V617F JAK2 mutation are clonal hematopoietic stem cell disordersLeukemia, 2006
- Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective studyThe Lancet, 2005
- JAK2V617F mutation in essential thrombocythaemia: clinical associations and long‐term prognostic relevanceBritish Journal of Haematology, 2005
- Clinical implications of the JAK2 V617F mutation in essential thrombocythemiaLeukemia, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005
- Clonality Analysis of Hematopoiesis in Essential Thrombocythemia: Advantages of Studying T Lymphocytes and PlateletsBlood, 1997